Pfizer and BioNTech ask EU to clear vaccine for 12 to 15-year-olds

They have already applied for emergency US authorisation of their jab for 12 to 15-year-olds earlier this month.

Pfizer/BioNTech will seek approval from the European Medicines Agency to approve their Covid vaccine for use on 12-15-year-olds.

Pfizer/BioNTech will seek approval from the European Medicines Agency (EMA) to approve their Covid vaccine for use on 12-15-year-olds.

In a statement on Friday, the two companies said their submission to the EMA was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective.